Express Pharma
Express Pharma
Browsing tag
SCD-044
Sun Pharma ends development of SCD-044 after phase 2 trials fail to meet primary endpoints
Read more
Sun Pharma starts Phase II trial of SCD-044 for moderate to severe plaque psoriasis
Read more
SPARC and Sun Pharma enter into license agreement for SCD-044
Read more